Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Oct 15;202 Suppl 2(Suppl 2):S309-14.
doi: 10.1086/655653.

Viral evolution and escape during acute HIV-1 infection

Affiliations
Review

Viral evolution and escape during acute HIV-1 infection

Christian L Boutwell et al. J Infect Dis. .

Abstract

The extensive genetic diversity of human immunodeficiency virus type 1 (HIV-1) presents a significant barrier to the development of an effective and durable HIV vaccine. This variability not only makes it difficult to identify the targets against which immune responses should be directed, but it also confers on the virus the capacity for rapid escape from effective immune responses. Here, we describe recent investigations of the genetic diversity of HIV-1 at transmission and of the evolution of the virus as it adapts to the host immune environment during the acute phase of HIV-1 infection. These studies increase our understanding of the virology of the earliest stages of HIV-1 infection and provide critical insights into the mechanisms underlying viral replication and immune control of diverse HIV-1 strains. Such knowledge will inform the design of smarter, more effective vaccines capable of inducing immune control of HIV-1.

PubMed Disclaimer

Conflict of interest statement

No author has a commercial or other association that might pose a conflict of interest.

Figures

Figure 1
Figure 1. Differential founder virus replication and immune escape from dominant CD8+ T cell responses combine to influence the HIV-1 set-point viral load and clinical course
The differential replication of wild type (solid line) and attenuated (dashed line) founder viruses results in different levels of peak viremia and long-term control of HIV-1. The impact of dominant CD8+ T cell responses (red cells) on the viral population is determined by the relative rate of escape in the targeted epitopes (grey diamonds) which ranges from immediate escape (top set-point line) as the result of the escape mutations being transmitted in the founder virus to never (bottom set-point line) as the result of high escape-associated fitness costs and low viral replication. The differential founder virus replication and dominant CD8+ T cell response effectiveness result in poor control of acute HIV-1 replication and high set-point viral load (red set-point line), normal control and set-point (green lines), and protective control and low to undetectable set-point (blue set-point lines).

References

    1. Streeck H, Jolin JS, Qi Y, et al. Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol. 2009;83:7641–8. - PMC - PubMed
    1. Carrington M, O’Brien SJ. The influence of HLA genotype on AIDS. Annu Rev Med. 2003;54:535–51. - PubMed
    1. Chohan B, Lang D, Sagar M, et al. Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1–V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J Virol. 2005;79:6528–31. - PMC - PubMed
    1. Rong R, Bibollet-Ruche F, Mulenga J, Allen S, Blackwell JL, Derdeyn CA. Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection. J Virol. 2007;81:1350–9. - PMC - PubMed
    1. Abrahams MR, Anderson JA, Giorgi EE, et al. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol. 2009;83:3556–67. - PMC - PubMed

Publication types